Syncom Formulations (India) Share Price
20.03+0.02 (+0.10%)
+15.31% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
SYNCOMFNSE
Syncom Formulations (India) Share Price
20.03+0.02 (+0.10%)
+15.31% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 20% | 28% | 77% |
| - | 37% | 36% | 95% |
| - | - | 33% | 15% |
| 10% | 11% | 11% | 16% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
SYNCOMF
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 20.03 | ₹1883 Cr | 22.01 | 0.26 | 0.98 | ₹76 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — |
| ₹94 Cr | ₹94 Cr | ₹94 Cr | ₹86 Cr | ₹78 Cr | ₹78 Cr | ₹78 Cr | ₹78 Cr | ₹22 Cr |
| ₹0 | ₹0 | ₹0 | ₹5 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹248 Cr | ₹194 Cr | ₹162 Cr | ₹131 Cr | ₹39 Cr | ₹31 Cr | ₹22 Cr | ₹17 Cr | ₹65 Cr |
| ₹248 Cr | ₹194 Cr | ₹162 Cr | ₹131 Cr | ₹39 Cr | ₹31 Cr | ₹22 Cr | ₹17 Cr | ₹65 Cr |
| ₹342 Cr | ₹288 Cr | ₹256 Cr | ₹222 Cr | ₹117 Cr | ₹109 Cr | ₹100 Cr | ₹95 Cr | ₹88 Cr |
| ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr | ₹7 Cr | ₹6 Cr |
| ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹58 L | ₹42 L | ₹17 L | ₹12 L | ₹2 Cr |
| ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹12 Cr | ₹10 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹43 Cr | ₹24 Cr | ₹20 Cr | ₹14 Cr | ₹32 Cr | ₹47 Cr | ₹20 Cr | ₹29 Cr | ₹19 Cr |
| ₹8 Cr | ₹6 Cr | ₹7 Cr | ₹3 Cr | ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹86 L | ₹2 Cr |
| ₹5 Cr | ₹72 Cr | ₹83 Cr | ₹58 Cr | ₹12 Cr | ₹6 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr |
| ₹7 Cr | ₹6 Cr | ₹3 Cr | ₹4 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹5 Cr |
| ₹62 Cr | ₹109 Cr | ₹113 Cr | ₹78 Cr | ₹59 Cr | ₹66 Cr | ₹37 Cr | ₹42 Cr | ₹28 Cr |
| ₹416 Cr | ₹407 Cr | ₹378 Cr | ₹308 Cr | ₹184 Cr | ₹181 Cr | ₹143 Cr | ₹144 Cr | ₹124 Cr |
| ₹86 L | ₹55 L | ₹55 L | ₹55 L | ₹3 Cr | ₹83 L | ₹83 L | ₹82 L | ₹2 Cr |
| ₹5 Cr | ₹72 Cr | ₹83 Cr | ₹58 Cr | ₹12 Cr | ₹6 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹146 Cr | ₹136 Cr | ₹102 Cr | ₹101 Cr | ₹92 Cr | ₹82 Cr | ₹80 Cr | ₹77 Cr | ₹74 Cr |
| ₹68 Cr | ₹63 Cr | ₹59 Cr | ₹54 Cr | ₹37 Cr | ₹37 Cr | ₹35 Cr | ₹27 Cr | ₹24 Cr |
| ₹78 Cr | ₹72 Cr | ₹43 Cr | ₹47 Cr | ₹55 Cr | ₹46 Cr | ₹46 Cr | ₹50 Cr | ₹50 Cr |
| ₹0 | ₹0 | ₹26 Cr | ₹6 Cr | ₹25 L | ₹5 Cr | ₹0 | ₹0 | ₹0 |
| ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹36 Cr | ₹23 Cr | ₹6 Cr | ₹9 Cr | ₹7 Cr |
| ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹36 Cr | ₹23 Cr | ₹6 Cr | ₹9 Cr | ₹7 Cr |
| ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹6 Cr | ₹15 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr |
| ₹14 Cr | ₹7 Cr | ₹76 Cr | ₹64 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹143 Cr | ₹130 Cr | ₹196 Cr | ₹168 Cr | ₹97 Cr | ₹89 Cr | ₹59 Cr | ₹66 Cr | ₹62 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹89 Cr | ₹64 Cr | ₹62 Cr | ₹41 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹41 Cr | ₹21 Cr | ₹21 Cr | ₹20 Cr | ₹10 Cr | ₹15 Cr | ₹11 Cr | ₹10 Cr | ₹6 Cr |
| ₹108 Cr | ₹103 Cr | ₹76 Cr | ₹68 Cr | ₹46 Cr | ₹46 Cr | ₹31 Cr | ₹29 Cr | ₹29 Cr |
| ₹71 L | ₹68 Cr | ₹9 Cr | ₹39 L | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr |
| ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr | ₹6 Cr | ₹6 Cr | ₹9 Cr | ₹6 Cr | ₹6 Cr |
| ₹30 Cr | ₹20 Cr | ₹10 Cr | ₹8 Cr | ₹18 Cr | ₹18 Cr | ₹25 Cr | ₹28 Cr | ₹17 Cr |
| ₹272 Cr | ₹277 Cr | ₹182 Cr | ₹140 Cr | ₹87 Cr | ₹92 Cr | ₹84 Cr | ₹78 Cr | ₹62 Cr |
| ₹211 Cr | ₹168 Cr | ₹69 Cr | ₹62 Cr | ₹28 Cr | ₹26 Cr | ₹47 Cr | ₹36 Cr | ₹33 Cr |
| ₹416 Cr | ₹407 Cr | ₹378 Cr | ₹308 Cr | ₹184 Cr | ₹181 Cr | ₹143 Cr | ₹144 Cr | ₹124 Cr |
| ₹4 | ₹3 | ₹3 | ₹3 | ₹2 | ₹1 | ₹1 | ₹1 | ₹39 |
| ₹4 | ₹3 | ₹3 | ₹3 | ₹2 | ₹1 | ₹1 | ₹1 | ₹1 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 |
|---|---|---|---|---|---|---|---|---|
| ₹66 Cr | ₹34 Cr | ₹27 Cr | ₹26 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr | ₹8 Cr |
| -₹11 Cr | -₹3 Cr | -₹6 Cr | -₹7 Cr | ₹71 L | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| -₹16 Cr | -₹28 Cr | -₹3 Cr | ₹4 Cr | ₹1 Cr | ₹12 Cr | -₹12 Cr | -₹6 Cr | -₹3 Cr |
| ₹38 Cr | ₹2 Cr | ₹17 Cr | ₹23 Cr | ₹18 Cr | ₹30 Cr | ₹7 Cr | ₹11 Cr | ₹8 Cr |
| ₹23 Cr | -₹6 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr | ₹24 Cr | ₹19 L | ₹7 Cr | ₹6 Cr |
| -₹18 Cr | ₹83 Cr | -₹45 Cr | -₹27 Cr | -₹18 Cr | -₹23 Cr | ₹63 L | -₹4 Cr | -₹32 L |
| -₹68 Cr | -₹15 Cr | ₹35 Cr | ₹8 Cr | ₹5 Cr | -₹2 Cr | ₹68 L | -₹93 L | -₹6 Cr |
| -₹63 Cr | ₹63 Cr | ₹58 L | -₹2 Cr | ₹83 L | -₹1 Cr | ₹1 Cr | ₹2 Cr | -₹92 L |
| ₹63 Cr | ₹88 L | ₹30 L | ₹3 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr |
| ₹71 L | ₹63 Cr | ₹88 L | ₹30 L | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Syncom Formulations (India) Share Price
20.03+0.02 (+0.10%)
+15.31% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 1 out of 9 oscillators
RSI
60.16Buy
STOCH %K
64.90Neutral
MACD Level(12,26)
0.89Buy
Ultimate Oscillator
53.18Buy
Aroon Oscillator
58.00Buy
BOP
0.02Buy
CCI
34.87Neutral
Williams %R
-35.10Neutral
Momentum
-1.33Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
19.78Buy
SMA 9
19.50Buy
EMA 21
19.12Buy
SMA 21
19.66Buy
EMA 50
17.43Buy
SMA 50
16.52Buy
EMA 200
15.48Buy
SMA 200
14.33Buy
WMA 20
19.80Buy
Pivot
Pivot
Classic
Resistance 5
23.64
Resistance 4
22.77
Resistance 3
21.90
Resistance 2
21.03
Resistance 1
20.52
Pivot
20.16
Support 1
19.65
Support 2
19.29
Support 3
18.42
Support 4
17.55
Support 5
16.68
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Syncom Formulations (India) Share Price
20.03+0.02 (+0.10%)
+15.31% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 50.57% | 50.57% | 50.57% | 50.57% | 50.57% | 50.57% |
| 0.35% | 0.21% | 0.26% | 0.10% | 0.41% | 0.11% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 49.08% | 49.22% | 49.17% | 49.33% | 49.02% | 49.32% |
Bulk & block deals
Name
Hrti Private Limited
Graviton Research Capital Llp
Hrti Private Limited
Graviton Research Capital Llp
Graviton Research Capital Llp
Hrti Private Limited
Graviton Research Capital Llp
Hrti Private Limited
Hrti Private Limited
Graviton Research Capital Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 09 Sep 2024 | Purchase | 21.56 Cr | ₹25.26 | 85.36 L | Bulk | 0.908106 | NSE |
| 09 Sep 2024 | Purchase | 17.70 Cr | ₹24.91 | 71.07 L | Bulk | 0.756026 | NSE |
| 09 Sep 2024 | Sell | 20.49 Cr | ₹25.14 | 81.50 L | Bulk | 0.867071 | NSE |
| 09 Sep 2024 | Sell | 17.67 Cr | ₹24.86 | 71.07 L | Bulk | 0.756026 | NSE |
| 06 Sep 2024 | Purchase | 12.48 Cr | ₹23.42 | 53.29 L | Bulk | 0.566944 | NSE |
| 06 Sep 2024 | Purchase | 11 Cr | ₹23.37 | 47.07 L | Bulk | 0.50075 | NSE |
| 06 Sep 2024 | Sell | 12.50 Cr | ₹23.46 | 53.29 L | Bulk | 0.566944 | NSE |
| 06 Sep 2024 | Sell | 11.92 Cr | ₹23.40 | 50.95 L | Bulk | 0.542006 | NSE |
| 26 Aug 2024 | Purchase | 15.77 Cr | ₹20.78 | 75.90 L | Bulk | 0.807456 | NSE |
| 26 Aug 2024 | Purchase | 11.07 Cr | ₹20.77 | 53.31 L | Bulk | 0.567172 | NSE |
Insider trading & SAST
Client name
Shankarlal Bankda Huf
Kedarmal Shankarlal Bankda
Vijay Shankarlal Bankda & Pacs
Asha Bankda
Vimla Bankda
Kedarmal Shankarlal Bankda
Asha Vijay Bankda
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 Jun 2023 | Promoter Group | Disposal | 0.290582 | 0 | 0 | — | 27.31 L | 15 Jun 2023 | Off Market | 0 | Insider Trading | — | Equity Shares |
| 16 Jun 2023 | Promoter & Director | Acquisition | 0.290582 | 12.44 | 0 | — | 27.31 L | 15 Jun 2023 | Off Market | 11,69,26,120 | Insider Trading | — | Equity Shares |
| 10 Jun 2022 | Promoter | Acquisition | 1.44 | 27.77 | 0 | — | 1.35 Cr | 28 May 2022 | Pref. Allotment | 26,09,91,699 | SAST | 29(2) | — |
| 09 Jun 2022 | Promoter Group | Acquisition | 1.565303 | 4.9 | 3.42 Cr | ₹2.53 | 1.35 Cr | 28 May 2022 | Conversion of security | 4,60,54,319 | Insider Trading | — | Equity Shares |
| 09 Jun 2022 | Promoter Group | Acquisition | 4.643383 | 4.26 | 10.13 Cr | ₹2.53 | 4 Cr | 28 May 2022 | Conversion of security | 4,00,59,320 | Insider Trading | — | Equity Shares |
| 09 Jun 2022 | Promoter | Acquisition | 2.78276 | 12.15 | 6.07 Cr | ₹2.53 | 2.40 Cr | 28 May 2022 | Conversion of security | 11,41,94,650 | Insider Trading | — | Equity Shares |
| 28 Feb 2022 | Promoter Group | Acquisition | 3.915884 | 3.77 | 8.22 Cr | ₹2.53 | 3.25 Cr | 25 Feb 2022 | Conversion of security | 3,25,54,319 | Insider Trading | — | Equity Shares |
Syncom Formulations (India) Share Price
20.03+0.02 (+0.10%)
+15.31% past 1 Year
Syncom Formulations (India) Ltd. is engaged in the business of pharmaceutical formulations. The company manufactures range of products in various dosage forms and markets them in various countries. In addition
Corporate Actions
Date
Type
Details
Company details
Syncom Formulations (India) Share Price
20.03+0.02 (+0.10%)
+15.31% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Syncom Formulations (India) Share Price
20.03+0.02 (+0.10%)
+15.31% past 1 Year
News
Syncom Formulations Q4 FY Results: Net profit rises despite lower revenue
Equity
SYNCOMF
Syncom Formulations Q3 FY26 Results: Net Profit Growth Amid Revenue Decline
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations reports Profit after tax of 15.73 Crores, in the June 2025 quarter
Equity
SYNCOMF
Syncom Formulations (India) informs about certificate
Equity
SYNCOMF
Syncom Formulations (India) informs about disclosure
Equity
SYNCOMF
Syncom Formulations reports Profit after tax of 6.42 Crores, in the December 2023 quarter
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations reports Profit after tax of 6.21 Crores, in the September 2023 quarter
Equity
SYNCOMF
Syncom Formulations (India) informs about annual general meeting
Equity
SYNCOMF
Syncom Formulations reports Profit after tax of 4.25 Crores, in the June 2023 quarter
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations reports Profit after tax of 8.47 Crores, in the March 2023 quarter
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF
Syncom Formulations - Quaterly Results
Equity
SYNCOMF